Crossmark

Cannabidiol enhancement of exposure therapy in treatment refractory patients with phobias: study protocol of a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12888-019-2022-x

Published Online: 2019-02-13

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

van der Flier, Febe E. http://orcid.org/0000-0002-2034-8720
Kwee, Caroline M. B.

Cath, Danielle C.

Batelaan, Neeltje M.

Groenink, Lucianne

Duits, Puck

van der Veen, Date C.

van Balkom, Anton J. L. M.

Baas, Johanna M. P.
Funding

Funding for this research was provided by:

ZonMw (40-41200-98-9269)
License Information

Text and Data Mining valid from 2019-02-13
More Information

Article History

Received: 6 March 2018

Accepted: 11 January 2019

First Online: 13 February 2019

Ethics approval and consent to participate

: The study has been approved by the Medical Ethics Committee of the University Medical Centre Utrecht (reference number: NL50898.041.15). Written informed consent will be obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.